Physician profile
Jesley Johnson
NPI 1265792253
$2,544.40
in general payments reported to CMS, 2019-2025
19 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $217 · 2021: $238 · 2022: $588 · 2023: $300 · 2024: $728 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $399.71 | 2020-2025 | |
| Visioneering Technologies, INC. | $333.28 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $270.81 | 2019-2023 | Cequa, Xelpros |
| Tarsus Pharmaceuticals, INC. | $253.31 | 2024 | Xdemvy |
| Bausch & Lomb Americas INC. | $245.58 | 2022-2025 | Miebo, Alden Corneal Gp, Vyzulta |
| Novartis Pharmaceuticals Corporation | $220.65 | 2019-2023 | |
| Biotissue Holdings INC. | $198.22 | 2024 | |
| Oyster Point Pharma, INC. | $141.35 | 2023 | Tyrvaya |
| Shire North American Group INC | $82.48 | 2019 | |
| Kala Pharmaceuticals, INC. | $76.16 | 2021-2022 | |
| Horizon Therapeutics Plc | $53.39 | 2023 | Tepezza |
| Alcon Vision LLC | $52.01 | 2019-2025 | Eysuvis, Tryptyr |
| Dompe US, INC. | $51.40 | 2020-2023 | Oxervate |
| Allergan, INC. | $42.96 | 2022 | |
| Coopervision INC. | $41.96 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.74 | 2019 | |
| Abbvie INC. | $21.10 | 2022 | |
| Eyevance Pharmaceuticals LLC | $18.05 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesley Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.